Zoetis Inc. (NYSE:ZTS – Get Free Report) EVP Roxanne Lagano sold 923 shares of Zoetis stock in a transaction on Friday, November 17th. The shares were sold at an average price of $177.46, for a total transaction of $163,795.58. Following the completion of the sale, the executive vice president now directly owns 22,665 shares of the company’s stock, valued at approximately $4,022,130.90. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.
Roxanne Lagano also recently made the following trade(s):
- On Wednesday, October 18th, Roxanne Lagano sold 923 shares of Zoetis stock. The shares were sold at an average price of $172.92, for a total transaction of $159,605.16.
- On Monday, September 18th, Roxanne Lagano sold 923 shares of Zoetis stock. The shares were sold at an average price of $179.58, for a total value of $165,752.34.
- On Friday, September 1st, Roxanne Lagano sold 923 shares of Zoetis stock. The shares were sold at an average price of $192.97, for a total value of $178,111.31.
Zoetis Price Performance
Shares of Zoetis stock traded up $1.26 during trading on Monday, hitting $176.06. 1,056,233 shares of the stock traded hands, compared to its average volume of 1,973,395. The firm’s fifty day moving average is $171.85 and its 200-day moving average is $175.65. The stock has a market cap of $80.83 billion, a price-to-earnings ratio of 35.53, a PEG ratio of 2.85 and a beta of 0.83. Zoetis Inc. has a 52 week low of $140.76 and a 52 week high of $194.99. The company has a quick ratio of 2.16, a current ratio of 3.87 and a debt-to-equity ratio of 1.29.
Zoetis Announces Dividend
Hedge Funds Weigh In On Zoetis
Several institutional investors and hedge funds have recently made changes to their positions in ZTS. Quantinno Capital Management LP boosted its position in Zoetis by 2.6% during the second quarter. Quantinno Capital Management LP now owns 18,431 shares of the company’s stock valued at $3,174,000 after buying an additional 475 shares during the period. Artisan Partners Limited Partnership bought a new position in Zoetis during the 1st quarter worth approximately $16,589,000. FirstPurpose Wealth LLC increased its stake in Zoetis by 3.7% in the 2nd quarter. FirstPurpose Wealth LLC now owns 2,126 shares of the company’s stock worth $366,000 after purchasing an additional 75 shares during the period. FORVIS Wealth Advisors LLC boosted its stake in shares of Zoetis by 4.7% during the second quarter. FORVIS Wealth Advisors LLC now owns 1,350 shares of the company’s stock valued at $232,000 after purchasing an additional 61 shares during the period. Finally, Arcataur Capital Management LLC purchased a new position in shares of Zoetis in the second quarter worth $442,000. Institutional investors own 89.47% of the company’s stock.
Wall Street Analysts Forecast Growth
Several brokerages have weighed in on ZTS. StockNews.com cut Zoetis from a “strong-buy” rating to a “buy” rating in a research note on Sunday, October 8th. The Goldman Sachs Group raised their price objective on shares of Zoetis from $204.00 to $213.00 and gave the company a “buy” rating in a research report on Wednesday, August 9th. Piper Sandler boosted their price target on shares of Zoetis from $210.00 to $215.00 and gave the company an “overweight” rating in a research report on Monday, November 6th. Argus increased their price objective on Zoetis from $190.00 to $201.00 in a research report on Tuesday, September 19th. Finally, Stifel Nicolaus reduced their target price on Zoetis from $205.00 to $195.00 and set a “buy” rating for the company in a research report on Monday, October 30th. Seven investment analysts have rated the stock with a buy rating, According to MarketBeat, the company currently has an average rating of “Buy” and an average price target of $216.29.
Zoetis Inc discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.
- Five stocks we like better than Zoetis
- What is the S&P/TSX Index?
- The most upgraded stocks in November have two things in common
- Investing in the High PE Growth Stocks
- Monday.com rocked earnings like it’s the weekend
- Technology Stocks Explained: Here’s What to Know About Tech
- Plan to own one retailer? Make it this one
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.